Aflibercept
VGFTe-AMD-1211
Approved small_molecule completed
Quick answer
Aflibercept for Exudative Macular Degeneration is a Approved program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Exudative Macular Degeneration
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed